Accession Number: | 0001209191-21-065256 |
Date: | 2021-11-15 |
Issuer: | TENET HEALTHCARE CORP (THC) |
Original Submission Date: |
RITTENMEYER RONALD A
14201 DALLAS PARKWAY
DALLAS, TX 75254
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-11-15 | S | 29,974 | d | $80.38 | 760,397 | direct | ||
COMMON STOCK | 2021-11-16 | S | 19,353 | d | $80.17 | 741,044 | direct | ||
COMMON STOCK | 2021-11-15 | 0 | $0.00 | 15,000 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | these shares were sold in open market broker transactions. |
f2 | the price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. these shares were sold in multiple transactions at prices ranging from $80.25 to $80.58. the reporting person undertakes to provide to the company, any security holder of the company or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price. |
f3 | the price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. these shares were sold in multiple transactions at prices ranging from $80.10 to $80.31. the reporting person undertakes to provide to the company, any security holder of the company or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price. |